DUBLIN--(BUSINESS WIRE)--The "Pulmonary Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's offering.
This report on the global pulmonary drug delivery devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031.
Companies Mentioned
- Boehringer Ingelheim GmbH
- Novartis AG
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd.
- AstraZeneca plc
- Merck & Co., Inc.
- MannKind Corporation
- F. Hoffmann-La Roche Ltd.
- Bristol-Myers Squibb Company
- Mylan N.V.
- Omron Corporation
- 3M Healthcare
- Sunovion Pharmaceuticals, Inc.
- Koninklijke Philips N.V.
- Gerresheimer AG
- Bespak
- AptarGroup, Inc.
- SHL Group
- Nypro Healthcare Inc. (Jabil Circuit Inc.)
- Hovione
- Chiesi Farmaceutici S.p.A.
The report provides revenue of the global pulmonary drug delivery devices market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global pulmonary drug delivery devices market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the pulmonary drug delivery devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global pulmonary drug delivery devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global pulmonary drug delivery devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global pulmonary drug delivery devices market.
The report delves into the competitive landscape of the global pulmonary drug delivery devices market. Key players operating in the global pulmonary drug delivery devices market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global pulmonary drug delivery devices market profiled in this report.
Key Topics Covered:
1. Preface
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Overview
4.1. Product Type Overview
4.2. Key Industry Events
4.3. Market Opportunity Map
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunity Analysis
5.5. Opportunities
5.6. Trends
5.7. Porter's Five Forces Analysis
5.8. Value Chain Snapshot
6. Global Pulmonary Drugs Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type
6.4. Global Pulmonary Drug Delivery Devices Market Forecast, by Product Type
6.4.1. Global Dry Powder Inhalers (DPIs) Market Revenue (US$ Mn) and Volume (Million Units), 2017-2031
6.4.2. Global Metered Dose Inhalers (MDIs) Market Revenue (US$ Mn) and Volume (Million Units), 2017-2031
6.4.3. Global Nebulizers Market Revenue (US$ Mn) and Volume (Million Units), 2017-2031
6.5. Global Pulmonary Drugs Market Attractiveness Analysis, by Product Type
6.6. Key Trends
7. Global Pulmonary Drug Delivery Devices Market Analysis, by Application
7.1. Key Findings
7.2. Introduction
7.3. Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2017 and 2031
7.4. Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and volume (Million Units) Forecast, by Application, 2017-2031
7.4.1. Global Asthma Market Revenue (US$ Mn) and volume (Million Units), 2017-2031
7.4.2. Global COPD Market Revenue (US$ Mn) and volume (Million Units), 2017-2031
7.4.3. Global Cystic Fibrosis Market Revenue (US$ Mn) and volume (Million Units), 2017-2031
7.4.4. Global Other Applications Market Revenue (US$ Mn) and volume (Million Units), 2017-2031
7.4.5. Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application
7.5. Key Trends
8. Pulmonary Drug Delivery Devices Market Analysis, by Distribution Channel
8.1. Key Findings
8.2. Introduction
8.3. Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2017 and 2031
8.4. Global Pulmonary Drug Delivery Devices Market Size (US$ Mn) and Volume (Million Units) Forecast, by Distribution Channel, 2017-2031
8.4.1. Global Retail Pharmacies Market Revenue (US$ Mn) and Volume (Million Units), 2017-2031
8.4.2. Global Hospital Pharmacies Market Revenue (US$ Mn) and Volume (Million Units), 2017-2031
8.4.3. Global E-commerce Market Revenue (US$ Mn) and Volume (Million Units), 2017-2031
8.5. Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel
9. Pulmonary Drug Delivery Devices Market Analysis, by Region
10. North America Pulmonary Drug Delivery Devices Market Analysis
11. Europe Pulmonary Drug Delivery Devices Market Analysis
12. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis
13. Latin America Pulmonary Drug Delivery Devices Market Analysis
14. Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis
15. Competition Landscape
15.1. Global Pulmonary Drugs Market Share Analysis, by Company, 2015
15.2. Competitive Dashboard
15.3. Pipeline Snapshot
16. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/no55jf
